FIXED ANTIHYPERTENSIVE DRUGS COMBINATION SELECTION WITH THE AIM OF ORGANS PROTECTION

FIXED ANTIHYPERTENSIVE DRUGS COMBINATION SELECTION WITH THE AIM OF ORGANS PROTECTION

The article focuses on the problems of choice among the antihypertension drugs combinations according to organs protection properties. It is underlined that target organs damage (microalbuminuria, pulse wave rate velocity increase, myocardial hypertrophy of the left ventricle, atherosclerotic plaque...

Full description

Bibliographic Details
Main Authors:	O. D. Ostroumova, I. I. Kopchenov, O. V. Bondarets, T. F. Guseva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-05-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension antihypertension drugs fixed combinations left ventricle myocardium hypertrophy microalbuminuria cognitive functions enalapril lercanidipine.
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/332

Similar Items

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION
by: L. O. Minushkina
Published: (2013-10-01)

From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift
by: O D Ostroumova, et al.
Published: (2015-12-01)

Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence
by: Antza C, et al.
Published: (2016-11-01)

Combined pharmacotherapy for arterial hypertension: a view through the 2013 clinical practice guidelines
by: A V Rodionov
Published: (2013-06-01)

TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS
by: A. M. Shilov, et al.
Published: (2015-09-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL)
by: N. M. Chihladze, et al.
Published: (2016-01-01)

Pleiotropic effects of antihypertensive therapy variants
by: S. V. Malchikova, et al.
Published: (2009-04-01)

HYPERTENSIVE HEART DISEASE IN COVERT ARTERIAL HYPERTENSION OF A LARGE FACTORY EMPLOYEE
by: A. N. Britov, et al.
Published: (2015-02-01)

Experience of using a fixed-dose combination of perindopril and amlodipine in the clinical practice settings: a real-world opportunity to increase antihypertensive therapy effectiveness
by: O. D. Ostroumova, et al.
Published: (2013-10-01)

COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Losartan effectiveness in arterial hypertension patients (ELLA study)
by: I. E. Chazova, et al.
Published: (2007-04-01)

ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. Part 2. Antihypertensive and Organoprotective Effects of Amlodipine/Lisinopril Fixed-Dose Combination in Patients with Arterial Hypertension in the Presence of Overweight and Obesity
by: O. D. Ostroumova, et al.
Published: (2017-12-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE)
by: S. Yu. Martsevich, et al.
Published: (2017-07-01)

Combination therapy of hypertension
by: O. O. Bolshakova
Published: (2015-12-01)

Clinical efficacy and cardioprotective capabilities of olmesartan and lercanidipine in the form of monotherapy and with their combined use in patients with arterial hypertension 1-2 degree
by: A. G Evdokimova, et al.
Published: (2017-03-01)

CLINICAL EFFECTS AND RENOPROTECTIVE FACILITIES OF OLMESARTAN AND LERKANIDIPINEAS MONOTHERAPY AND WHEN COMBINED APPLICATION IN PATIENTS WITH ARTERIAL HYPERTENSION
by: A G Evdokimova, et al.
Published: (2016-03-01)

Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
by: O. Yu. Korennova, et al.
Published: (2019-01-01)

Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
by: Vivencio Barrios, et al.
Published: (2008-08-01)

DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
by: O D Ostroumova, et al.
Published: (2016-12-01)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
by: Ostroumova O.D., et al.
Published: (2016-12-01)

Combined antihypertensive medications
by: L. L. Kirichenko, et al.
Published: (2007-12-01)

Fixed-dose versus separate drug combinations for antihypertensive treatment: literature review
by: José Luis Calleja Rivero
Published: (2016-09-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE
by: A. A. Kudryavtsev, et al.
Published: (2016-01-01)

ANTIHYPERTENSIVE EFFICACY AND VASOPROTECTIVE PROPERTIES OF A NEW COMBINATION OF BETA-BLOCKER, BISOPROLOL (2,5/5 MG) AND DIURETIC, HYDROCHLOROTHIAZIDE (6,25 MG)
by: O. D. Ostroumova, et al.
Published: (2016-01-01)

ANALYSIS OF THE PRACTICE OF COMBINATIONAL ANTIHYPERTENSION THERAPY BY THE DATA FROM TWO OUTPATIENT REGISTRIES
by: S. Yu. Martsevich, et al.
Published: (2017-10-01)

Comparison of circadian blood pressure profile in Stage 2-3 arterial hypertension patients receiving different antihypertensive combinations
by: S. D. Mayanskaya, et al.
Published: (2011-12-01)

Effects of a fixed-dose combination of ACE inhibitor and nondihydropyridine calcium antagonist on endothelial dysfunction in patients with essential arterial hypertension
by: O. D. Ostroumova, et al.
Published: (2010-04-01)

PREDICTION ROLE OF THE LEFT VENTRICLE REMODELLING IN ARTERIAL HYPERTENSION PATIENTS
by: S. V. Ivanova, et al.
Published: (2016-12-01)

PREDICTION ROLE OF THE LEFT VENTRICLE REMODELLING IN ARTERIAL HYPERTENSION PATIENTS
by: S. V. Ivanova, et al.
Published: (2016-12-01)

Calcium antagonist lercanidipine in hypertension
by: G. A Baryshnikova, et al.
Published: (2014-03-01)

CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
by: I. O. Minushkina
Published: (2015-02-01)

Antihypertensive combination therapy effects on cardiac remodelling in elderly patients
by: L. Kh. Gadzhieva, et al.
Published: (2013-10-01)

Three-year dynamics of left ventricular structural parameters in patients with resistant arterial hypertension on four-component therapy
by: О. О. Matova, et al.
Published: (2020-12-01)

ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE
by: R. M. Linchak, et al.
Published: (2016-01-01)

FIXED COMBINATION OF VALSARTAN AND AMLODIPINE: EFFECTS ON THE LEFT VENTRICULAR HYPERTROPHY REGRESSION, ALBUMINURIA REDUCTION AND ENDOTHELIUM FUNCTION IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
by: Ye. I. Tarlovskaya, et al.
Published: (2016-01-01)

Target organ damage in newly detected hypertensive patients
by: Divya Prakash
Published: (2019-01-01)